Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Nanavaty Maulik
Relationship:  
City:   Natick
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   177,758    

Indirect Shares

  11,017      
Direct Value   $13,395,387    

Indirect Value

  $0      
Total Shares   188,775      
Total Value   $13,395,387      


Boston Scientific Corp
 $13,395,387 Rani Therapeutics Holdings, Inc.
 $0 Boston Scientific Corp
 $13,395,387 Rani Therapeutics Holdings, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    2    

     Stock price went up :

    0   
    2    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   2.0   
     Percentage Gain/Loss :
     0.0%
 6.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Boston Scientific Corp BSX SVP & Pres, Neuromodul... 2022-02-28 177,258 0    Premium*  
            Rani Therapeutics Holdings, Inc. RANI 2023-11-16 500 2023-11-16 11,017    Premium*  
* Premium Members only  

Records found :    176         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2021-02-10 4 A $0.00 $0 D/D 6,477 241,636 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2016-01-01 4 D $18.44 $125,337 D/D (6,797) 146,778 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2020-08-28 4 OE $17.26 $118,248 D/D 6,851 266,993 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2015-02-23 4 D $16.31 $116,633 D/D (7,151) 125,363 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2014-02-24 4 D $13.08 $93,666 D/D (7,161) 93,582 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2020-01-01 4 OE $0.00 $0 D/D 7,950 263,144 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2019-02-20 4 D $40.11 $319,235 D/D (7,959) 252,123 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2019-10-03 4 OE $13.08 $125,869 D/D 9,623 264,817 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2019-10-03 4 AS $39.25 $377,744 D/D (9,623) 255,194 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2019-11-04 4 AS $41.66 $400,894 D/D (9,623) 255,194 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2019-11-04 4 OE $13.08 $125,869 D/D 9,623 264,817 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2019-12-04 4 OE $13.08 $125,869 D/D 9,623 264,817 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2019-12-04 4 AS $42.89 $412,712 D/D (9,623) 255,194 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2020-01-02 4 AS $45.33 $436,214 D/D (9,623) 260,219 0 %
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2020-01-02 4 OE $13.08 $147,239 D/D 9,623 269,842 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2020-02-03 4 AS $42.17 $405,802 D/D (9,623) 255,194 0 %
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2020-02-03 4 OE $16.31 $156,951 D/D 9,623 264,817 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2020-03-02 4 OE $16.31 $156,951 D/D 9,623 276,354 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2021-01-01 4 OE $0.00 $0 D/D 9,791 238,784 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2018-01-01 4 OE $0.00 $0 D/D 10,005 218,238 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2019-01-01 4 OE $0.00 $0 D/D 10,750 244,101 0 -
RANI Rani Therapeutics Holding... Director   –       •      –    2022-02-03 4 A $0.00 $0 I/I 11,017 11,017 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2016-02-22 4 D $17.26 $219,426 D/D (12,713) 167,893 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2017-02-28 4 D $24.55 $315,026 D/D (12,832) 207,091 0 -
BSX Boston Scientific Corp SVP & Pres, Neuromodulation   •       •      –    2020-02-14 4 A $0.00 $0 D/D 13,440 268,634 0 -

  176  Records found
  1   2   3   4   5   6  7   8      
  Page 6 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed